FDA
approval
· 2019-04-26
FDA Approved: BOSENTAN — Original Application (Actavis Pharma, Inc.)
Summary
FDA approved a generic bosentan from Actavis Pharma under an original ANDA (ANDA207110). The approval covers its use for pulmonary arterial hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BOSENTAN (BOSENTAN)